BioDech: A Global Life Sciences Broadcast Series
In today's competitive landscape, life sciences companies routinely face a myriad of legal complexities and regulatory issues, from early-stage financing for clinical trials and IPO preparedness, to antitrust, securities or patent disputes post-product launch. Despite the challenges, innovation in the market is more active than ever.
To help companies navigate these issues, BioDech brings together life sciences industry leaders with lawyers from Dechert’s cross-practice global life sciences team to discuss the challenges and opportunities that may arise at every phase of the life sciences life cycle, from discovery through development, clinical testing, promotion and sales.
Latest Episode: Episode 6 – One in Four: What Makes Life Sciences Companies So Vulnerable to Securities Class Actions
September 14, 2023 – Joni Jacobsen, co-chair of the global securities and complex litigation team and Angela Liu, securities litigation partner are joined by Tiffany Engsell, Senior Counsel, Litigation & Government Investigations, Bristol Myers Squibb, to discuss securities fraud class actions against U.S. life sciences companies and what to look out for after your company becomes public.
Joni Jacobsen | Partner & Co-Chair, Global Securities and Complex Litigation, Dechert
Angela Liu | Partner, Securities Litigation, Dechert
Tiffany Engsell | Senior Counsel, Litigation & Government Investigations, Bristol Myers Squibb
About Dechert's Life Sciences Practice
Dechert’s life sciences group delivers industry expertise and commercial judgment to help leading life sciences companies navigate their most complex and demanding transactional, intellectual property and litigation matters. Our global multi-disciplinary team has the reach, resources and experience to provide comprehensive transactional, regulatory and dispute resolution services anywhere in the world. Learn more.